7.Yayınlar

7.1 Uluslararası hakemli dergilerde yayınlanan makaleler

1. Berber E, Kavaklı K, Akar N, Berber E, Caglayan SH. R506Q (FV Leiden) and R485K Mutations in the Factor V Gene: Incidence in Deep Venous Thrombosis and Hemophilia A patients. Turk J Haematol 20: 221-225, 2003.
2. O’Brien L, James P, Othman M, Berber E, Cameron C, Notley C, Hagerdorn C, Hough C, O’Shaunessy D, Rivard G, Members of the Association of Hemophilia Clinic Directors of Canada, Lillicrap D. A founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 102: 549-557, 2003. DOI: 10.1182/blood-2002-12-3693
3. Hough C, Cuthbert C, Notley C, Brown B, Berber E, Lillicrap D. Cell type-specific regulation of von Willebrand factor expression by the E4BP4 transcriptional repressor. Blood 105: 1531-1539, 2005. DOI: 10.1182/blood-2002-10-3093
4. Berber E, Leggo J, Brown C, Berber E, Gallo N, Feillotter H, Lillicrap D. DNA microarray analysis for the detection of mutations in Hemophilia A. Journal of Thrombosis and Haemostasis 4: 1756-1762, 2006. DOI: 10.1111/j.1538-7836.2006.02055.x
5. Berber E, Fidanci I, Un C, Maarri O, Aktuglu G, Gurgey A, Oldenburg J, Graw J, Caglayan SH. Sequencing of the Factor 8 (F8) Coding Regions in 10 Turkish Hemophilia A Patients reveals three novel pathological mutations, one rediagnosis of von Willebrand Disease type 2N. Hemophilia 12: 398-400, 2006.
6. Hough C, Cameron C, Notley C, Keightley A, O’Brien L, Berber E, Lillicrap D. Influence of upstream polymorphic haplotypes on shear stress responsiveness of the von Willebrand factor gene promoter. Journal of Thrombosis and Haemostasis 7: 1183-1190, 2008.
7. Agan K, Yalcin O, Caglayan HS, Berber E, Aykut-Bingol C. Analysis of the Asn752Thr Polymorphisim in exon 16 of the Kcnq2 gene in four families afflicted with Idiopathic Generalized Epilepsy (Ige). The Internet Journal of Genomics and Proteomics 4, 2009.
8. Berber E, James PD, Hough C, Lillicrap D. An assessment of the pathogenic significance of the R924Q von Willebrand Factor substitution. Thrombosis and Haemostasis 7; 1672-1679, 2009.
9. Berber E. Rimoldi V, Usluer S, Aksu S, Caglayan SH, Duga S, Characterization of the genetic basis of FXI deficiency in two Turkish Patients. Haemophilia. 2010 May;16(3):564-6.
10. Berber E. Molecular Characterization of FXI deficiency. Clin Appl Thromb Hemost. 2011; 17(1):27-32.
11. Oymak Y, Dodurga Y, Turedi A, Yaman Y, Ozek G, Carti O, Gunes BT, Erbudak E, Berber E, Avci CB, Vergin C. Higher Expression of the Novel Gene Upregulated Gene 4 in Two Acute Lymphoblastic Leukemia Patients with Poor Prednisolone Response. Acta Haematol. 2012; 128(2):73-76.
12. Berber E, The Molecular Genetics of von Willebrand Disease. Turkish Journal of Hematology. 2013; 29: 313-324.
13. Berber E, Pehlevan F, Akin M, Yalcin Capan O, Kavakli K, Caglayan SH. A Common VWF Exon 28 Haplotype in the Turkish Population. Clin Appl Thromb Hemost. 2013; 19: 550-556.
14. Kilic SC, Icagasioglu FD, Guven AS, Berber E. Spontaneous thrombosis in a patient with factor XI deficiency homozygous for the p.Cys398Tyr mutation. Blood Transfusion 2014; 12: 446-448.
15. Berber E, Özbil M, Brown C, Baslar Z, Caglayan S.H., Lillicrap D. Functional Characterization of the Type 1 VWD candidate VWF gene variants: p.M771I, p.L881R and p.P1413L (034-16). Blood Transfusion 2017; 15(6): 548-556 (DOI 10.2450/2016.0034-16).
16. Colakoglu S, Bayhan T, Berber E. Molecular genetic analysis of FXI gene in 14 Turkish FXI deficiency patients: identification of novel and recurrent mutations and inheritance of the mutations within the family. Blood Transfusion 2018; 16(1):115-113 (DOI 10.2450/2016.0098-16).
17. Baltaci OF, Colakoglu S, Gullu Amuran G, Aydin N, Sargin M, Karabay A, Yilmaz T, Berber E. Exploring the role of miRNAs in the diagnosis of miRNAs in the diagnosis of MODY3. Turkish Journal of Medical Sciences 2018; 48(3): 620-626.
18. Capan OY, Aydin N, Yilmaz T, Berber E. Whole exome sequencing reveals novel candidate gene variants for MODY. CLINICA CHIMICA ACTA 2020; 510: 97-104.
19. Kavaklı K, Antmen B, Okan V, Şahin F, Aytaç S, Balkan C, Berber E, Kaya Z, Küpesiz A and Zülfikar B. Gene therapy in haemophilia: literature review and regional perspectives for Turkey. Therapeutic Advances in Hematology 2022; 13:1-17.

7.2 Uluslararası bilimsel toplantılarda sunulan ve bildiri kitabında basılan bildiriler

1. Berber E, Timur A, Berber E, Erbil Y, Çağlayan SH. FV Leiden Mutation associated with Activated Protein C Resistance (APCR) and Thrombosis, 2nd International Uludağ Oncology Symposium, 31 October-1 November 1997, Bursa, Turkey.
2. Berber E, Çağlayan SH. A Silent Mutation in an Individual Heterozygous for FV Leiden Mutation, 30th. Annual Meeting of the European Society of Human Genetics, 10-13 May 1998, Lisbon, Portugal.
3. Berber E, Timur A, Berber E, Aktuğlu G, Erbil Y, Çağlayan SH. Detection of FV Leiden Mutation by ARMS and DGGE Method, 15th. International Congress on Thrombosis, 16-21 October 1998, Antalya, Turkey.
4. Berber E, Timur A, Çağlayan SH. A Silent Mutation in the Factor V Gene of Factor V Leiden Carrier, 15th. International Congress on Thrombosis, 16-21 October 1998, Antalya, Turkey.

5. O. Yalcin, E. Berber, Agan K, Aykut-Bingol C, Çağlayan HS. Analysis of the Asn752Thr Polymorphisim in the Kcnq2 gene in Three families Affected with Idiopathic Generalized Epilepsy (Ige), HGM 2001, Human genome Meeting, 19-22 April, 2001, Edinburg-Scotland.
6. Berber E, Cameron C, Hough C, Çağlayan SH, Lillicrap D. Shear Stress Response Elements in the 5′ Regulatory Region of the von Willebrand Gene, Mutation Detection 2001, VI. International Symposıum on Mutations in the Human Genome, 03-07May, 2001, Bled, Slovenia.
7. Cameron C, Keightley A, Berber E, Hough C, Lillicrap D. Evidence for Allele-Specific Shear Stress Responsiveness of the von Willebrand Factor regulatory Sequence, XVIII Congress: The International Society on Thrombosis and Haemostasis, ISTH Paris, July 6-12, 2001, France.
8. James P, Notley C, Cameron C, O’Brien L, Hagerdorn C, Berber E, Hough C, Rivard EG, AHCDC, Lillicrap D. The Spectrum of Phenotype/Genotype Association in Type I von Willebrand Disease: Results from the Canadian Type I VWD Study, 45th American Society of Hematology Meeting, December 6-9, 2003, San Diego, California, USA.
9. Berber E, James PD, Leggo J, Collen N, Hagerdorn C, Cameron C, the Association of Hemophilia Clinic Directors of Canada, Lillicrap D. Effect of the R924Q von Willebrand Factor Substitution on the Expression of the von Willebrand Disease Phenotype, 45th American Society of Hematology Meeting, December 6-9, 2003, San Diego, California, USA. (Sözlü Sunum)
10. Berber E, James P, Shibata M, Leggo J, O’Brien L, Hough C, Lillicrap D. Detailed biosynthetic analysis of the Y1584C and R924Q von Willebrand Factor variants, 46th American Society of Hematology Meeting, December 4-9, 2004, San Diego, California, USA.
11. Berber E, Leggo J, Brown C, Hough C, Berber E, Gallo N, Feilotter H, Lillicrap D. A Pilot Study of a DNA Microarray-Based Approach for the Screening of Mutations in Hemophilia A. XX. Congress of the ISTH, 6-12 August 2005, Sydney, Australia.
12. Usluer S, Berber E, Çağlayan S, Pekcelen Y, Unuvar A. Establishment of High resolution Melting Analysis for VWF gene mutation scanning in Turkish patients. Hemophilia 2008 World Congress, 1-5 June 2008, İstanbul, Turkey.
13. Usluer S, Berber E, Çağlayan SH, Pekcelen Y, Aksu S. Autosomal dominant inheritance of FXI defiency in two Turkish patients. Hemophilia 2008 World Congress, 1-5 June 2008, Istanbul, Turkey.
14. H. Çağlayan, Usluer S, Pekcelen Y, Berber E, Aksu S, T33P Substitution and W519X Mutation in Two Turkish Patients with the FXI Deficiency. XXII. Congress of the International Society on Thrombosis and Haemostasis, July 11-16, 2009, Boston-USA.
15. Berber E, Dagdemir A, Pehlevan F, Akin M, Kavakli K, Çağlayan S. Presence of a common haplotype in the Turkish VWD patients. XXIX International Congress of the WFH, Buenos Aires, Argentina, 10 Temmuz 2010 – 14 Temmuz 2010, ss.147-147.
16. Zulfikar B, Gurhan O, Bezgal F, Berber E. Sex-change surgery in a type 3 VWD patient, XXIII Congress of the International Society on Thrombosis and Haemostasis 57th Annual SSC Meeting, Kyoto, Japan, 23 Temmuz 2011 – 28 Temmuz 2011, ss.912-912.
17. Berber E, Brown C, Incekara K, Baslar Z, Çağlayan H, Lillicrap D. Functional Characterization of the Type 1 VWD Candidate VWF Gene Variants: P.M771I, p.L881R, p.P1413L, and p.Q1475X. 54TH ASH Annual Meeting and

5

Exposition, Atlanta, USA, 08 Aralık 2012 – 11 Aralık 2012, ss.149 (Sözlü Sunum)

18. Yalcın Capan O, Sozen I, Lembet A, Aydin N, Berber E. GCK mutations are not common cause for MODY2 and Gestational Diabetes in Turkey. European Human Genetics Conference, 2013, Paris, Fransa.
19. Yalcin Capan O, Sargin M, Berber E, HNF1A gene analysis in the MODY suspected Turkish patients, European Human Genetics Conference, 2013, Paris, Fransa.
20. Buyukpınarbasili Y, Berber E, Zulfikar H, Bezgal F, Kilicaslan Ş, Bali F, Balmumcu IH, Zulfikar B. Organisational design of non-governmental organisations related to hemophilia: An example from Turkey. WFH 2014 World Congress, Melbourne, Australia, 11 Mayıs 2014 – 15 Ekim 2014, ss.144-144.
21. Berber E, Oymak Y, Baltaci OF, Diz-Kücükkaya R, Zulfikar OB, Kavakli K. Presence of P.Q852R Variation with High Frequency in the Turkish VWD patients, 18th International Meeting of the Danubian League against Thrombosis and Haemorrhagic Disorders, May 14-16, 2015, SaraJevo, Bosnia and Herzegovina.(Sözlü Sunum)
22. Yalçın-Çapan Ö, Baltacı OF, Berber E. Functional analysis of HNF1A variants in MODY patients. 4th International Congress of the Molecular Biology Association of Turkey. November 27-29, 2015, ODTÜ, Ankara, Türkiye.
23. Berber E, Oymak Y, Baltaci OF, Diz-Kucukkaya, R, Zulfikar, BO, Kavakli, K. Identification of novel vwf gene mutations in the Turkish type 2 VWD patient population. J Thromb. Haemost. ISTH 2015, Toronto, Canada, June 20-25, 2015.
24. Berber E. Oturum Başkanı. 13. Uluslararası Hemofili Kongresi, 17-19 Nisan 2016, İstanbul, Türkiye.
25. Zulfikar B, Buyukpunarbasulu Y, Kulucoglu O, Ak G, Koc B, Berber E, Ozdemir N, Ovalu F, Turkmen C, Zulfikar H. Regional hemophilia project in Turkey. JUL 2016, Hemophilia, Vol.: 22, Pages: 57-57, Supplement: 4, Special Issue: SI, Orlando, USA.
26. Berber E, Taskan E, Forghieri G, Colakoglu S, Baltaci O, Koc B, Oymak Y. Functional characterization of c.4876instgc and c2555a > g VWF gene variants identified Type 2 VWD patient population in turkey.Journal of Thrombosis and Haemostasis, Vol.: 14, Pages: 148-148, Supplement: 1, Special Issue: SI, Meeting Abstract: VWF12, MAY 2016, Montpellier, France.
27. Baltaci OF, Colakoglu S, Gullu G, Karabay Korkmaz A, Berber E. Identification of the functional miRNA/miRNAs in the pathogenesis of MODY3. ESHG 2016, May 20-26, Barcelona, Spain.
28. Yalçın Çapan O, Baltaci OF, Selçuk E, Berber E. Functional Characterization of p.T10M and p.S345K mutations in HNF1A Gene in MODY patients. ESHG 2016, May 20-26, Barcelona, Spain.
29. Yılmaz-Keskin E, Ayhan E, Çolakoğlu Ş, Fettah A, Keskin M, Berber E. Lack of Association of Plasma Factor XI with Bleeding and Report of Two Noverl Factor VII Mutations. Leukemia Research.Vol. 49, S1, ISSN 0145-2126.
30. Colakoglu S, Aydın N, Baltacı OF, Sargın M, Berber E, Yılmaz T. Searching for Maturity-Onset Diabetes of the Young in Turkey by genetic Diagnosis. ESHG 2017, May 27-30, Copenhagen, Denmark.
31. Koc B, Colakoglu S, Berber E, Zulfikar B. A correlation between the genotype and clinical course in hemophilia B patients. Hemophilia Vol. 25, S1, Pages 57-57. Meeting Abstract: P056, Published: Feb 2018.

32. O. Bülent Zülfikar, Seda Genç, Volkan Yalman, Başak Koç, Ergül Berber. Hemofili B olgularında Somatik Mozaiklik. 18. Uluslararası Türkiye Hemofili kongresi 2021, Eylül 18-20, Kıbrıs.(Sözlü Sunum)
33. O. Bülent Zülfikar, Seda Genç, Mehmet Özbil, Başak Koç, Okan V, Kavaklı K, Antmen B, Şahin F, Gunes AM, Ay Y, Albayrak C, Unal M, Dağlı M, Berber E. Molecular Characterization Of The F9 Missense Variants. ISTH 2021, July 4-7, England.

7.3 Yazılan Uluslararası kitaplar veya kitaplarda bölümler

7.4. Ulusal Dergilerdeki Yayınlar

1. 1. Berber E, Kavaklı K, Akar N, Berber E, Caglayan SH. R506Q (FV Leiden) and R485K Mutations in the Factor V Gene: Incidence in Deep Venous Thrombosis and Hemophilia A patients. Turk J Haematol 20: 221-225, 2003.

7.5 Ulusal Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında Basılan Bildiriler

1. Berber E, Çağlayan SH. FVIII-Ekson 14, Ser1269Ser (c.3864A>C) Polimorfizmi: Türk toplumundaki sıklığı ve doğum öncesi tanıda kullanımı, 2. Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi, 07-08 Kasım, 2001, İstanbul, Türkiye.
2. Berber E, Akar N, Çağlayan SH. Türk popülasyonunda FVIII-Ekson 14 A>C polimorfizmi (Ser1269Ser), Türk Hematoloji Derneği 29. Ulusal Kongresi, 25-28 Ekim, 2002, Kemer, Antalya, Türkiye.
3. Berber E, Çağlayan S. H., Faktör VIII’i kodlayan gen bölgesinde mutasyon bulunamayan Hemofili hastaları, Türk Hematoloji Derneği 29. Ulusal Kongresi, 25-28 Ekim, 2002, Kemer, Antalya, Türkiye.
4. Berber E, Hemofili Genetiği ve Prenatal Tanı, 5. Ulusal Hemofili Kongresi, 26-30 Haziran 2006, Çeşme, İzmir. (Davetli Konuşmacı)
5. Berber E, James P, Hough C, Lillicrap D. R924Q von Willebrand Faktör Değişikliğinin Tip 1 ve tip 2N von Willebrand Hastalığının patogenezindeki önemi, VII. Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi, 04-06 Mayıs 2007, Adana. (Sözlü Sunum)
6. Berber E, Von Willebrand Hastalığı Genetiği, 6. Ulusal Hemofili Kongresi, 7-10 Mayıs 2009, Antalya, Türkiye. (Davetli Konuşmacı)
7. Özcan A, Karsidag S, Şirvan SS, Sucu DO, Pehlevan F, Ugurlu K, Berber E. Sporadik Malign Melanomlu Hastalarda CDKN2A Gen Mutasyonları, 31. Türk Plastik, Rekonstrüktif ve Estetik Cerrahi Ulusal Kongresi 2009, Adana. (Sözlü Sunum)
8. Berber E. VWH’da Moleküler Genetik, 7. Ulusal Hemofili Kongresi, 15-17 Nisan 2010, İstanbul. (Davetli konuşmacı)
9. Berber E. Von Willebrand Hastalığının Moleküler Genetiği ve Ulusal Veriler, 8. Ulusal Hemofili Konğresi, 5-8 Mayıs 2011, Antalya. (Davetli konuşmacı)
10. Berber E. Kalıtsal Kanama Hastalıklarında Genetik Danışmanlık, 37. Ulusal Hematoloji Kongresi, 19-22 Ekim 2011, Ankara, Türkiye (Davetli Konuşmacı) 7

11. Berber E. Molecular Diagnosis of von Willebrand Disease. Von Willebrand ve Nadir Faktör Eksiklikleri Sempozyumu, 2012, İstanbul. (Davetli Konuşmacı)
12. Berber E. Faktör XI ve von Willebrand Faktör Genlerinin Yüksek Çözünürlüklü Erime Analizi ve Doğrudan DNA Dizilemesi ile Mutasyon Analizi, 9. Türkiye Hemofili Kongresi, 12-17 Nisan 2012, İstanbul. (Sözlü Sunum)
13. Berber E, Ö. Yalçın Çapan, K. İncekara, S. Çağlayan, Ö.O. Çakır, G. Özışık, K. Karşıdağ, M.E. Önde, Türk Mody hastalarında GCK ve HNF1A gen analizi, 48. Ulusal Diyabet Kongresi, Antalya, 9-13 Mayıs 2012. (Sözlü Sunum)
14. Berber E, VWF Biyosentezinin Patofizyolojik mekanizmasının Analizi. 38. Ulusal Hematoloji Kongresi, 31 Ekim-3 Kasım 2012, Antalya, Türkiye. (Sözlü Sunum)
15. Berber E, MODY3’ün tanınsında miRNA’ların rolünün araştırılması, 54. Ulusal Diyabet Kongresi, 18-22 Nisan 2018, Antalya, Türkiye (Sözlü Sunum).

7.6 Diğer Yayınlar

Kitaplar:

1. Zülfikar B, Berber E, Zülfikar H. (Editörler.), 11. Uluslararası Türkiye Hemofili Kongresi Kongre Kitabı. ISBN:978-605-64753-0-6, 17-20 Nisan, 2014, Istanbul.

1. Yılmaz, S., Maraklı, S., Yüzbaşıoğlu, G., & Gözükırmızı, N. (2018). Short-term mutagenicity test by using IRAP molecular marker in rice grown under herbicide treatment. Biotechnology & Biotechnological Equipment, 32, 0–0.

2. Yüzbaşıoğlu, G., Maraklı, S., & Gözükırmızı, N. (2017). Screening of Oryza sativa L for Hpt Gene and Evaluation of Hpt Positive Samples Using Houba Retransposon-Based IRAP Markers. Turkish Journal of Agricultural Research (TUTAD), 0–0.

3. Yalçın, S., Ünver Alçay, A., Yüzbaşıoğlu, G., Çakmak Sancar, B., & Sağlam, (2017). A Study on Prevalence of Escherichia coli O157 with a Verified Method in Foods. Turkish Science and Technology Publishing (TURSTEP), 5, 0–0.

4. Yüzbaşıoğlu, G., Yılmaz, S., And Gözükırmızı, N. 2016. Houba retrotransposon-based molecular markers a tool for variation analysis in rice. The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) – DIGITAL COMMONS JOURNALS 40, 0–0.

5. Yüzbaşıoğlu, G., Yılmaz, S., Maraklı, S., & Gözükırmızı, N. (2016). Analysis of Hopi Osr27 and Houba Tos5 Osr13retrotransposons in rice. Informa UK Limited, 30, 0–0..

6. Sezer, , Yüzbaşıoğlu, G., Özbilen, A., & Taşkın, K. M. (2016). Genome- wide identification and expression analysis of SWI1 genes in Boechera species. Elsevier BV, 62, 0–0.

1. Uyar, R. (2022). Glioblastoma microenvironment: The stromal interactions. Pathology-Research and Practice, 232, 153813.

2. Zhao, D., Zhang, H., Uyar, R., Hossain, J. , Miletic, H., Tonn, J.-C., … Kaelin, R. E. (2021). Comparing Tumor Cell Invasion and Myeloid Cell Composition in Compatible Primary and Relapsing Glioblastoma. MDPI AG, 13(14), 0–0.

1. Teke Tunçel, Ş., Demir, İ., Erdem, S., & Doğan, H. İ. (2023). Stable hemiaminals from axially chiral pyridine compounds. Chirality, 0–0.

2. Teke Tunçel, Ş., & Doğan, İ. (2020). Synthesis of thiazol-2-imines from the reduction of single enantiomer 2-imino-thiazolidin-4-ones followed by a spontaneous water elimination. Chirality, 0–0.

3. Erol Günal, Ş., Teke Tunçel, Ş., & Doğan, H. İ. (2020). Enantiodiscrimination of carboxylic acids using single enantiomer thioureas as chiral solvating agents. Tetrahedron, 0–0.

4. Teke Tunçel, Ş., Erol Günal, Ş., Ekizoğlu, , Gökhan Kelekçi, N., Erdem, S., Bulak, F. E., … Doğan, H. İ. (2019). Thioureas and their cyclized derivatives Synthesis conformational analysis and antimicrobial evaluation. Journal of Molecular Sturcture, 0–0.

5. Erol Günal, Ş., Teke Tunçel, Ş., Gökhan Kelekçi, N., Uçar, G., Yüce Dursun, B., Erdem, S., & Doğan, H. İ. (2018). Asymmetric synthesis molecular modeling and biological evaluation of 5-methyl-3- aryloxazolidine-2 4-dione enantiomers as monoamine oxidase MAO inhibitors. Bioorganic Chemistry, 0–0.

1. Acquaviva, A., Cristina Di Simone, S., Nilofar, N., Bouyahya, A., ZENGİN, , Recinella, L., A. I. Uba, … Chiavaroli, A. (2023). Screening for Chemical Characterization and Pharmacological Properties of Different Extracts from Nepeta italica. Plants, 12(15), 1–17.

2. C. Baloğlu, L. Y. Yıldız Özer, B. Pirci, G. Zengin, A. I. Uba, And Y. Çelik Altunoğlu, “Evaluation of the Potential Therapeutic Properties of Liquidambar orientalis Oil,” Chemistry and Biodiversity, pp. 0–0, Sep. 2023.

3. I. E. Ibrahim, S. Yagi, T. Tzanova, H. Schohn, A. I. UBA, and G. ZENGİN, “Chemical profile antiproliferative and antibacterial activities and docking studies of essential oil and hexane fraction of hydrosol from fresh leaf of Plectranthus amboinicus Lour Spreng ,” Biochemical Systematics and Ecology, vol. 107, pp. 1–5, Apr. 2023.

4. Kurt-Celep, İ., ZENGİN, G., UBA, A. I., Caprioli, G., Mustafa, A. M., Angeloni, S., … Mahomoodally, M. F. (2023). Unravelling the chemical

profile   antioxidant   enzyme inhibitory   cytotoxic potential of different extracts from Astragalus caraganae. Archiv Der Pharmazie, 356(9), 1–19.

5. Acquaviva, , Nilofar, N., Bouyahya, A., ZENGİN, G., Di Simone, S. C., Recinella, L., UBA, A. I., … Chiavaroli, A. (2023). Chemical characterization of different extracts from Artemisia annua and their antioxidant enzyme inhibitory and anti inflammatory properties. Chemistry & Biodiversity – Wiley, 20(8), 1–8.

6. Kurt-Celep, I., Zengin, G., Celep, E., Dall’Acqua, S., Sut, S., Ferrase, I., UBA, A. I.,… & Mahomoodally, M. F. (2023). A multifunctional key to open a new window on the path to natural resources-lessons from a study on chemical composition and biological capability of Paeonia mascula L. from Turkey. Food Bioscience, 51, 102194.

7. Chiavaroli, , Libero, M. L., Di Simone, S. C., Acquaviva, A., Nilofar, N., Recinella, L., UBA, A. I., … Ferrante, C. (2023). Adding New Scientific Evidences on the Pharmaceutical Properties of Pelargonium quercetorum Agnew Extracts by Using In Vitro and In Silico Approaches. Plants, 12(5), 1–22.

8. Lazarova, I., ZENGİN, G., Piatti, D., UBA, A. I., Sagratini, G., Caprioli, G., … Venanzoni, R. (2023). Appraisals on the chemical characterization and biological potentials of Ranunculus constantinopolitanus extracts using chromatographic computational and molecular network Food and Chemical Toxicology, 181, 1–18.

9. Fahmy, N. M., Fayez, S., UBA, A. I., Shariati, M. A., Aljohani, A. S., El- Ashmawy, I. M., … ZENGİN, G. (2023). Comparative GC-MS Analysis of Fresh and Dried Curcuma Essential Oils with Insights into Their Antioxidant and Enzyme Inhibitory Activities. Plants, 12(9), 1–17.

10. Mahomoodally, M. F., ZENGİN, G., Roumita, S.-S., Roumita, S.-S., Caprioli, , Mustafa, A. M., UBA, A. I., … Demirci, F. (2023). Chemical Characterization and Multidirectional Biological Effects of Different Solvent Extracts of Arum elongatum in Vitro and in Silico Approaches. Chemistry and Biodiversity, 20(4), 1–12.

11. Kobenan, K. C., Kouadio, I. S., Kouakou, M., Silvie, P., Kouadio, K. N. B., N’goran, E., UBA, A. I… & Zengin, G. (2023). In Vitro and

Molecular Docking Evaluation of Larvicidal Effects of Essential Oils of Five Aromatic Plants on the Fall Armyworm Spodoptera frugiperda JE. Smith (Lepidoptera: Noctuidae) from Ivory Coast. Chemistry & Biodiversity, 20(8), e202300411.

12. Mahomoodally, M. F., ZENGİN, G., Roumita, S.-S., Roumita, S.-S., Caprioli, G., Mustafa, A. M., UBA, A. I… Demirci, F. (2023). Chemical Characterization and Multidirectional Biological Effects of Different Solvent Extracts of Arum elongatum in Vitro and in Silico Approaches. Chemistry and Biodiversity, 20(4), 1–12.

13. Kljakić, C., Božunović, J., Gašić, U., Roumita Seebaluck-Sandoram, R., UBA, A. I., Mahomoodally, M. F., UBA, A. I … ZENGİN, G. (2023).

Chemical characterization of Glaucosciadum cordifolium extracts obtained by different extraction techniques and their biopharmaceutical effects. PROCESS BIOCHEMISTRY, 134(1), 141–150.

14. ZENGİN, , Yagi,  S.,  Kopjar,  M.,  Ćorković,  I.,  UBA,  A.  I.,

YILDIZTUGAY, E., … Eid, A. H. (2023). A comparative study on chemical profiles and biological activities of different extracts of three Verbascum species from Turkey In vitro in silico and network pharmacological approaches. Biocatalysis and Agricultural Biotechnology, 52, 1–13.

15. Sut, , Dall’Acqua, S., ZENGİN, G., ŞENKARDEŞ, İ., UBA, A. I.,

Bouyahya, A., & AKTÜMSEK, A. (2023). Novel Signposts on the Road from Natural Sources to Pharmaceutical Applications A Combinative Approach between LC-DAD-MS and Offline LC-NMR for the Biochemical Characterization of Two Hypericum Species H montbretii and H origanifolium . Plants, 12, 1–25.

16. Acquaviva, A., Cristina Di Simone, S., Nilofar, N., Bouyahya, A., ZENGİN, G., Recinella, L., UBA, A. I., … Chiavaroli, A. (2023). Screening for Chemical Characterization and Pharmacological Properties of Different Extracts from Nepeta italica. Plants, 12(15), 1–17.

17. Sinan, K. I., ZENGİN, G., UBA, A. I., Caprioli, G., Angeloni, S., Vittori, S., … Mahomoodally, M. F. (2023). Chemical characterization and biological abilities of Anthocleista djalonensis collected from two locations of Ivory Coast. eFoods – Wiley, 4(2), 0–0.

18. UBA, A. I., & ZENGİN, G. (2023). Phenolic compounds as histone deacetylase inhibitors binding propensity and interaction insights from molecular docking and dynamics simulations. Amino Acids, 55(5), 579–

19. UBA, I., Paradis, N. J., Wu, C., & ZENGİN, G. (2023). Phenolic

compounds as potential adenosine deaminase inhibitors molecular docking and dynamics simulation coupled with MM-GBSA calculations. Amino Acids, 0–0.

20. UBA, A. I., Bui-Linh, C., Thornton, J. M., Olivieri, M., & Wu, C. (2023). Computational analysis of drug resistance of taxanes bound to human β- tubulin mutant D26E . Journal of Molecular Graphics and Modelling, 123, 1–13.

21. UBA, A. I., & ZENGİN, G. (2023). In the quest for histone deacetylase inhibitors current trends in the application of multilayered computational methods. Amino Acids, 0–0.

22. Usman, S. S., UBA, A. I., & Christina, E. (2023). Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to Molecular Biology Reports, 50, 7055–7067.

23. Świątek, Ł., Sieniawska, E., Sinan, K. I., ZENGİN, G., UBA, A. I., Bene, K., … AKTÜMSEK, A. (2022). Bridging the Chemical Profiles and Biological Effects of Spathodea campanulata Extracts A New Contribution on the Road from Natural Treasure to Pharmacy Shelves. Molecules, 27, 1–26.

24. Đorđevski, N., UBA, A. I., ZENGİN, G., Božunović, J., Gašić, U., Ristanović, E., … Stojković, D. (2022). Chemical and Biological Investigations of Allium scorodoprasum L Flower Extracts. Pharmaceuticals, 16, 1–20.

25. UBA, I., ZENGİN, G., Montesano, D., ÇAKILCIOĞLU, U., SELVİ, S.,

Ulusan, M. D., … Mahoomodally, M. F. (2022). Antioxidant and Enzyme Inhibitory Properties and HPLC MS MS Profiles of Different Extracts of Arabis carduchorum Boiss An Endemic Plant to Turkey. Applied Sciences, 12(13), 1–15.

26. BİRGÜL, K., Çuhadar, O., KOÇYİĞİT SEVİNÇ, S., Selen Tiryaki, S., MEGA TİBER, , ORUN, O., UBA, A. I., … KÜÇÜKGÜZEL, Ş. G.

(2022). Synthesis and molecular modeling of MetAP2 of thiosemicarbazides 1 2 4-triazoles thioethers derived from S -Naproxen as possible breast cancer agents. Journal of Molecular Structure, 1259, 1– 14.

27. ZENGİN, , Fahmy, N. M., Sinan, K. I., UBA, A. I., Bouyahya, A.,

Lorenzo, J. M., … Fayez, S. (2022). Differential Metabolomic Fingerprinting of the Crude Extracts of Three Asteraceae Species with Assessment of Their In Vitro Antioxidant and Enzyme-Inhibitory Activities Supported by In Silico Investigations. Processes, 10, 1–22.

28. Ozturk, R. B., ZENGİN, G., Sinan, K. I., Montesano, D., Zheleva- Dimitrova, D., Gevrenova, R., UBA, A. I., … Mahomoodally, M. F. (2022). Which Extraction Solvents and Methods Are More Effective in Terms of Chemical Composition and Biological Activity of Alcea fasciculiflora from Turkey . Molecules, 27, 1–21.

29. ZENGİN, , UBA, A. I., ÖÇAL, M., Sharifi-Rad, M., Caprioli, G.,

Angeloni, S., … YILDIZTUGAY, E. (2022). Integration of in vitro and in silico approaches to assess three Astragalus species from Turkey flora A novel spotlight from lab bench to functional applications. Food Bioscience, 49, 1–12.

30. Llorent-Martínez, J., Ruiz-Medina, A., ZENGİN, G., Ak, G., Jugreet, S., Mahomoodally, M. F., UBA, A. I., … Chiavaroli, A. (2022). New Biological and Chemical Evidences of Two Lamiaceae Species Thymbra capitata and Thymus sipyleus subsp rosulans In Vitro In Silico and Ex Vivo Approaches. Molecules, 27, 1–23.

31. Luca, V., Trifan, A., ZENGİN, G., Sinan, K. I., UBA, A. I., Korona-

Glowniak, I., & Skalicka-Woźniak, K. (2022). Evaluating the phyto- complexity and poly-pharmacology of spices The case of Aframomum melegueta K Schum Zingiberaceae . Food Bioscience, 49, 1–16.

32. Zengin, G., Dall’Acqua, S., Sinan, K. I., Uba, A. I., Sut, S., Peron, G., … & Mahomoodally, M. F. (2022). Gathering scientific evidence for a new bioactive natural ingredient: The combination between chemical profiles

and biological activities of Flueggea virosa extracts. Food Bioscience, 49, 101967.

33. Kurt-Celep, , Zheleva-Dimitrova, D., Gevrenova, R., UBA, A. I.,

ZENGİN, G., YILDIZTUGAY, E., … Montesano, D. (2022). An In-Depth

Study on the Metabolite Profile and Biological Properties of Primula auriculata Extracts A Fascinating Sparkle on the Way from Nature to Functional Applications. Antioxidant, 11, 1–34.

34. Omer, H. A. A., Caprioli, G., Abouelenein, D., Mustafa, A. M., UBA, A. I., Ak, G., … Yagi, S. (2022). Phenolic Profile Antioxidant and Enzyme Inhibitory Activities of Leaves from Two Cassia and Two Senna Species. Molecules, 27, 1–17.

35. Babandi, , Anosike, C. A., Ezeanyika, L. U. S., YELEKÇİ, K., & UBA,
36. I. (2022). Molecular modeling studies of some phytoligands from Ficus sycomorus fraction as potential inhibitors of cytochrome CYP6P3 enzyme of Anopheles coluzzii. Jordan Journal of Pharmaceutical Sciences, 15(2), 258–275.

36. UBA, A. I., & Wu, C. (2022). Identification of potential antagonists of CRF1R for possible treatment of stress and anxiety neuro-disorders using structure-based virtual screening and molecular dynamics simulation. Computational Biology and Chemistry, 100, 1–9.

37. UBA, A. I., Aluwala, H., Liu, H., & Wu, C. (2022). Elucidation of partial activation of cannabinoid receptor type 2 and identification of potential partial agonists Molecular dynamics simulation and structure-based virtual screening. Computational Biology and Chemistry, 99, 1–16.

38. UBA, I., Chea, J., Hoag, H., Hryb, M., Bui-Linh, C., & Wu, C. (2022).

Binding of a positive allosteric modulator CDPPB to metabotropic glutamate receptor type 5 mGluR5 probed by all-atom molecular dynamics simulations. Life Sciences, 309, 1–12.

39. Adamu, M., Singh, R. M., & UBA, A. I. (2021). Structure-based Virtual Screening of Natural Compounds as Potential Anti-Allergy Agents Against Cytokine Alarmins TSLP and IL-33 . Letters in Drug Design and Discovery, 18(9), 932–942.

40. Albayati, S., UBA, A. I., & YELEKÇİ, K. (2021). Potential inhibitors of methionine aminopeptidase type II identified via structure-based pharmacophore modeling. Molecular Diversity, 26, 1005–1016.

41. Adamu, M., Singh, R. M., Ibrahim, M. A., & UBA, A. I. (2021). Virtual discovery of a hetero-cyclic compound from the Universal Natural Product Database UNPD36 as a potential inhibitor of interleukin-33 molecular docking and dynamic simulations. Journal of Biomolecular Structure and Dynamics, 40(19), 8696–8705.

42. UBA, A. I., Scorese, N., Dean, E., Liu, H., & Wu, C. (2021). Activation Mechanism of Corticotrophin Releasing Factor Receptor Type 1 Elucidated Using Molecular Dynamics Simulations. ACS Chemical Neuroscience, 12(9), 1674–1687.

43. YILMAZ, Ö., Bayer, , BEKCİ, H., UBA, A. I., CUMAOĞLU, A.,

YELEKÇİ, K., & KÜÇÜKGÜZEL, Ş. G. (2020). Synthesis Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP Type II

. Medicinal Chemistry, 16, 735–749.

44. Weako, , UBA, A. I., KESKİN, Ö., GÜRSOY, A., & YELEKÇİ, K.

(2020). Identification of potential inhibitors of human methionine aminopeptidase type II for cancer therapy Structure-based virtual screening ADMET prediction and molecular dynamics studies. Computational Biology and Chemistry, 86, 1–10.

45. UBA, A. I., Radicella, C., Readmond, C., Scorese, N., Liu, H., & Wu, C. (2020). Binding of agonist WAY-267 464 and antagonist WAY-methylated to oxytocin receptor probed by all-atom molecular dynamics simulations. Life Sciences, 252, 1–16.

46. Birgül, , Yıldırım, Y., Karasulu, H. Y., Karasulu, E., Uba, A. I., Yelekçi, K., UBA, A. I., … Küçükgüzel, Ş. G. (2020). Synthesis molecular modeling in nbsp vivo study and anticancer activity against prostate cancer of S -naproxen derivatives. European Journal of Medicinal Chemistry, 208, 1–14.

47. Usman, S., Dahiru, M., Abdullahi, B., Abdullahi, S. B., Maigari, U. M., & UBA, A. I. (2019). Status of malondialdehyde catalase and superoxide

dismutase levels activities in schoolchildren with iron deficiency and iron- deficiency anemia of Kashere and its environs in Gombe State Nigeria. Heliyon, 5(8), 1–7.

48. Han, M. İ., Bekci, H., Uba, A. I., Yıldırım, Y., Karasulu, E., Cumaoğlu, A., … Küçükgüzel, Ş. G. (2019). Synthesis molecular modeling in vivo study and anticancer activity of 1 2 4 triazole containing hydrazide hydrazones derived from S Archiv Der Pharmazie, 352(6), 1– 14.

49. Uba, A. I., & Yelekçi, K. (2019). Crystallographic structure versus homology model a case study of molecular dynamics simulation of human and zebrafish histone deacetylase 10. Journal of Biomolecular Structure and Dynamics, 38(15), 4397–0.

50. Samorlu, A. S., UBA, A. I., & Yelekçi, K. (2019). The design of potent HIV-1 integrase inhibitors by a combined approach of structure-based virtual screening and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 37(17), 4644–4650.

51. UBA, A. I., & Yelekçi, K. (2019). Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors. Journal of Biomolecular Structure and Dynamics, 37(14), 3627–3636.

52. UBA, A. I., Weako, J., Keskin, Ö., Gürsoy, A., & Yelekçi, K. (2019). Examining the stability of binding modes of the co-crystallized inhibitors of human HDAC8 by molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 38(6), 1751–1760.

53. UBA, I., & Yelekçi, K. (2018). Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6. Computational Biology and Chemistry, 77, 318–330.

54. UBA, A. I., & Yelekçi, K. (2018). Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6 Structure-based virtual screening molecular docking and dynamics simulation studies. Computational Biology and Chemistry, 75, 131–142.

55. UBA, A. I., & Yelekçi, K. (2017). Exploration of the binding pocket of histone deacetylases the design of potent and isoform-selective Turkish Journal of Biology, 41(6), 901–918.

56. UBA, A. I., Tabakoğlu, H. Ö., Abdullahi, U. A., & Sani, M. M. (2017). Closure of skin incision by dual wavelength 980 and 1064 nm laser application. Journal of Cosmetic and Laser Therapy, 19(2), 109–113.

57. UBA, A. I., & YELEKÇİ, K. (2017). Identification of potential isoform- selective histone deacetylase inhibitors for cancer therapy a combined approach of structure-based virtual screening ADMET prediction and molecular dynamics simulation assay. Journal of Biomolecular Structure and Dynamics, 36(12), 3231–3245.

58. Abdulazeez, M., Aminu, H., Ndanusa, S., & UBA, A. I. (2016). Isolation and Characterization of a New Angiotensin-converting Enzyme Inhibitory Peptide fromHeterobronchus bidorsalis. Journal of Biologically Active Products From Nature, 6(3), 237–249.

59. TABAKOĞLU, Ö., Sani, M. M., UBA, A. I., & Abdullahi, U. A. (2015).

Assessment of circular wound healing in rats after exposure to 808-nm laser pulses during specific healing phases. Laser in Medicine and Surgery, 48, 409–415.

1. Cesur, N. P., Yalman, V., & Türkoğlu, N. (2021). Decellularization of tissues and organs. Cumhuriyet Medical Journal, 42(2), 0–0.

2. Yalman, V., Çelik, E., Arslan, Ömer, Alkan, Funda, Laçin Türkoğlu, Nelisa, Şirin, H. T., … Demirbilek, M. (2020). A study on bone tissue engineering Injectable chitosan-g-stearic acid putty. Technology and Health Care, 28(3), 227–239.

3. Cesur, P., Yalman, V., & Laçin, M. T. (2020). Decellularization of cow aorta via supercritical CO2. Journal of Applied Biological Sciences, 14(3), 268-280.

4. Yalman, V., & Türkoğlu, N. (2019). Development of humic acid and alginate-based wound dressing and evaluation on inflammation. Materials Technology, 34(12), 705–717.

1. Betül Baydar. (2018) Y.L Tezi, İnsan BCL-2 Genine Ait Promotör Bölgesinin Moleküler Analizi. Atatürk Üniversitesi